Genalyte Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$141.8M
Lead Investor(s):N/A

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Genalyte's estimated annual revenue is currently $31.9M per year.(?)
  • Genalyte received $36.0M in venture funding in November 2016.
  • Genalyte's estimated revenue per employee is $270,000
  • Genalyte's total funding is $141.8M.

Employee Data

  • Genalyte has 118 Employees.(?)
  • Genalyte grew their employee count by -1% last year.
  • Genalyte currently has 1 job openings.

In an age when information can be transmitted at the speed of light, physicians and patients should be able to expect reliable bloodwork results within minutes of a test being completed. Leaving a patient in limbo waiting days for results while test samples are shipped across the country is an unacceptable standard in the 21st century. Rapid test results that allow physicians to confidently make data-driven treatment decisions during a patient's office visit should become the new standard of care. Genalyte's vision is to transform the doctor-patient relationship by bringing the doctor, the patient, and the lab together to provide results when they matter: Now. Genalyte's platform is being designed with the goal of providing test results from a whole blood sample within fifteen minutes in the physician's office. Providing diagnostic results at the time and place they are needed when the patient is sitting in front of the doctor has the potential to empower physicians, improve quality of care for patients, and reduce resource utilization across the healthcare system. Genalyte's technology is based on a proprietary silicon biosensor design that is currently in use by pharmaceutical companies, contract research organizations and academic researchers. For more information, visit

keywords:Biotechnology,Healthcare,Healthcare Providers,Medical Diagnostics,Pharmaceuticals